Vanguard Capital Management
SER icon

Vanguard Capital Management’s Serina Therapeutics SER Stock Holding History

Vanguard Capital Management’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
162,198
+3,062
+2% +$5.75K ﹤0.01% 3778
2026
Q1 		$309K Buy
+159,136
New +$350K ﹤0.01% 3746

Other funds holding SER

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
WA
Waverly Advisors Birmingham, Alabama $17.2B AUM 24.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Capital Management's SER Position: Q2 2026 in Review

Vanguard Capital Management increased its Serina Therapeutics (SER) stake by 1.9% in Q2 2026, buying an estimated $5.75K and bringing the position to 162,198 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #3778.

Vanguard Capital Management first reported a position in SER in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold SER as of Q2 2026.

  • Vanguard Capital Management held 162,198 shares of Serina Therapeutics worth $315K as of Q2 2026.
  • Vanguard Capital Management bought 3,062 Serina Therapeutics shares in Q2 2026, an estimated $5.75K.
  • Serina Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3778 holding.
  • Vanguard Capital Management first reported a position in Serina Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.